Where the Money Is: Healthcare Technology

Scott Mace, for HealthLeaders Media , October 9, 2012

"Appliances" translates to purpose-built servers that drive analytics speed and efficiency. Those don't come cheap.

Khorey says it's money UPMC would spend anyway, and the system "will drive efficiencies that will pay for it." But the investment is also a mix of outcomes-oriented work and research, because personalized medicine based on analyzing genomic data is still a bit of a science project. "New models of care and good science is the UPMC agenda for personalized medicine," she says.

When UPMC looked around a year ago, no comparable institution had made a similar investment in personalized medicine analytics R&D. "We have friends at Intermountain and Kaiser and other large organizations that have huge analytics shops, but they tend to be focused on one facet of the problem, whereas we're basically saying it's a personalized medicine agenda, and we're going to solve the information management problem for all," Khorey says.

Of course the money can't just sit there for five years with nothing to show for it. "The goal is to do something quickly," Khorey says. She rattled off a punch list of early efforts: patient outcomes related to cardiothoracic patients; a small, intersecting set of breast cancer genomic and phenotypic data; some CMS quality compliance reporting. If any of them click, they can be scaled up quickly, she says.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "Where the Money Is: Healthcare Technology"

jkuriyan (10/9/2012 at 3:16 PM)
There are plenty of data warehouses in healthcare - most of them trying to catch "outliers". If I'm to use an analogy with accounting, we in healthcare are using "general ledgers" capturing all the transactions - and spotting the highest, lowest etc. We need to get to the next phase. In accounting it was the use of business ratios and similar ones in economics too. There is a huge amount of information buried in all these warehouses - but they are accessible only to a small group of people, most of them without the modern mathematical skills to get to the next stage. I wish they would set aside 10% of the funds in trying to revisit the data they already have - and develop some interesting new models, as economists have.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2016 a division of BLR All rights reserved.